Computer Vision News - April 2023

27 IBD Scoring with Clario knowledge can be embedded in an automated algorithm that will help bring benefit to the patients of the future,” Mishkin said. Clario, GI Reviewers, and RSIP Vision continue to collaborate to bring the benefits of AI to all aspects of IBD clinical trials. Upcoming plans include the expansion of the study to additional sites, AI-enabled extraction of rich and detailed video-based data to support deeper analytics by Pharma companies, expansion to Crohn’s disease scoring, AI-based automation of clinical trial enrollment, and ultimately the potential development of novel, quantitative, AI-enabled IBD scoring systems.